|
|
|
| Webinar: False Rejects Aren’t Inevitable: How to Reduce Waste and Improve Line Efficiency | False rejects can drain yield, slow production, and undermine confidence in inspection systems. In this Thermo Fisher webinar, experts will break down the causes of false rejects and share practical strategies to improve stability, reduce variability, and strengthen production performance. Attendees will also receive an actionable checklist to support consistent throughput, compliance, and product quality across operations. Click here to learn more. |
|
|
|
|
|
|
|
|
By Stefan Kettelhoit, Ph.D., and Norbert Waldöfner, Ph.D. | How API manufacturers can assess and mitigate organic impurities and nitrosamines using risk-based strategies aligned with global regulatory expectations. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| A Practical Guide To Checkweighing And Checkweighers | E-Book | Thermo Scientific Product Inspection | Nothing saves money like a checkweigher. A checkweigher weighs every product in motion to help you meet throughput and legal requirements. Delve into the technology and options for your application. |
|
|
|
| 5 Minutes With: Jeff Goldman, General Manager | Q&A/Interview | Ensorcell | A look at the motivations, challenges, and vision shaping a new approach to life science tools—focused on practical design, thoughtful engineering, and expanding access to technologies. |
|
|
| Scaling Clinical To Commercial With One CDMO | Article | Afton Scientific | Assessing whether to stay or switch CDMOs means balancing continuity benefits, capability gaps, and transfer costs to ensure efficient, low‑risk clinical‑to‑commercial progress. |
|
|
|
|
|
|
|
| Navigating Downstream Processing (DSP) | Article | Curia | DSP failures kill commercialization timelines. Gain insight into how integrated harvest, filtration, and purification infrastructure protects product stability at scale. |
|
|
|
| Targeted Modalities Set Elevated Standards For Precision | Article | By Anshul Gupte, Vice President, PCI Pharma Services | Observe how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes. |
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|